Pilot clinical study of boron neutron capture therapy for recurrent hepatic cancer involving the intra-arterial injection of a (10)BSH-containing WOW emulsion

Appl Radiat Isot. 2014 Jun:88:32-7. doi: 10.1016/j.apradiso.2014.01.014. Epub 2014 Jan 30.

Abstract

A 63-year-old man with multiple HCC in his left liver lobe was enrolled as the first patient in a pilot study of boron neutron capture therapy (BNCT) involving the selective intra-arterial infusion of a (10)BSH-containing water-in-oil-in-water emulsion ((10)BSH-WOW). The size of the tumorous region remained stable during the 3 months after the BNCT. No adverse effects of the BNCT were observed. The present results show that (10)BSH-WOW can be used as novel intra-arterial boron carriers during BNCT for HCC.

Keywords: Boron neutron capture therapy; Hepatocellular carcinoma; Intra-arterial injection; Water-in-oil-in-water emulsion.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Borohydrides / administration & dosage*
  • Borohydrides / chemistry
  • Boron Neutron Capture Therapy / methods*
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / radiotherapy*
  • Emulsions / administration & dosage
  • Emulsions / chemistry
  • Humans
  • Injections, Intra-Arterial
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / radiotherapy*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Recurrence, Local / radiotherapy*
  • Oils / chemistry
  • Pilot Projects
  • Sulfhydryl Compounds / administration & dosage*
  • Sulfhydryl Compounds / chemistry
  • Treatment Outcome
  • Water / chemistry

Substances

  • Borohydrides
  • Emulsions
  • Oils
  • Sulfhydryl Compounds
  • Water
  • mercaptoundecahydrododecaborate